630
Views
4
CrossRef citations to date
0
Altmetric
Brief Report

Impact of glucocorticoids on systemic sirtuin 1 expression and activity in rats with adjuvant-induced arthritis

, , , ORCID Icon, ORCID Icon, , , , & show all
Pages 132-143 | Received 02 Nov 2019, Accepted 28 May 2020, Published online: 13 Jul 2020

References

  • Viatte S, Plant D, Raychaudhuri S. Genetics and epigenetics of rheumatoid arthritis. Nat Rev Rheumatol. 2013;9:141–153.
  • McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007;7:429–442.
  • McInnes IB, Liew FY. Cytokine networks–towards new therapies for rheumatoid arthritis. Nat Clin Pract Rheumatol. 2005;1:31–39.
  • Vasanthi P, Nalini G, Rajasekhar G. Role of tumor necrosis factor-alpha in rheumatoid arthritis: a review. APLAR J Rheumatol. 2007;10:270–274.
  • Kay J, Calabrese L. The role of interleukin-1 in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford). 2004;43(Suppl 3):iii2–9.
  • Nalbant S, Birlik AM. Cytokines in Rheumatoid Arthritis (RA). New developments in the pathogenesis of rheumatoid arthritis. 2017. DOI:10.5772/65893.
  • Selmi C, De Santis M, Gershwin ME. Liver involvement in subjects with rheumatic disease. Arthritis Res Ther. 2011;13:226.
  • Brzustewicz E, Bryl E. The role of cytokines in the pathogenesis of rheumatoid arthritis–Practical and potential application of cytokines as biomarkers and targets of personalized therapy. Cytokine. 2015;76:527–536.
  • Herbein G, Wendling D. Histone deacetylases in viral infections. Clin Epigenetics. 2010;1:13–24.
  • Holroyd C, Harvey N, Dennison E, et al. Epigenetic influences in the developmental origins of osteoporosis. Osteoporos Int. 2012;23:401–410.
  • Grabiec AM, Tak PP, Reedquist KA. Targeting histone deacetylase activity in rheumatoid arthritis and asthma as prototypes of inflammatory disease: should we keep our HATs on? Arthritis Res Ther. 2008;10:226.
  • Yeung F, Hoberg JE, Ramsey CS, et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. Embo J. 2004;23:2369–2380.
  • Niederer F, Ospelt C, Brentano F, et al. SIRT1 overexpression in the rheumatoid arthritis synovium contributes to proinflammatory cytokine production and apoptosis resistance. Ann Rheum Dis. 2011;70:1866–1873.
  • Kotas ME, Gorecki MC, Gillum MP. Sirtuin-1 is a nutrient-dependent modulator of inflammation. Adipocyte. 2013;2:113–118.
  • Wang W, Yan C, Zhang J, et al. SIRT1 inhibits TNF-α-induced apoptosis of vascular adventitial fibroblasts partly through the deacetylation of FoxO1. Apoptosis. 2013;18:689–701.
  • Tanno M, Sakamoto J, Miura T, et al. Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J Biol Chem. 2007;282:6823–6832.
  • Correia M, Perestrelo T, Rodrigues AS, et al. Sirtuins in metabolism, stemness and differentiation. Biochim Biophys Acta. 2017;1861:3444–3455.
  • Tseng P-C, Hou S-M, Chen R-J, et al. Resveratrol promotes osteogenesis of human mesenchymal stem cells by upregulating RUNX2 gene expression via the SIRT1/FOXO3A axis. J Bone Miner Res. 2011;26:2552–2563.
  • C-M B, Li Y, Lindgren U, et al. Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells. J Bone Miner Res. 2006;21:993–1002.
  • Taylor DM, Maxwell MM, Luthi-Carter R, et al. Biological and potential therapeutic roles of sirtuin deacetylases. Cell Mol Life Sci. 2008;65:4000–4018.
  • Zeng L, Chen R, Liang F, et al. Silent information regulator, Sirtuin 1, and age-related diseases. Geriatr Gerontol Int. 2009;9:7–15.
  • He X, Andersson G, Lindgren U, et al. Resveratrol prevents RANKL-induced osteoclast differentiation of murine osteoclast progenitor RAW 264.7 cells through inhibition of ROS production. Biochem Biophys Res Commun. 2010;401:356–362.
  • Shakibaei M, Buhrmann C, Mobasheri A. Resveratrol-mediated SIRT-1 interactions with p300 modulate receptor activator of NF-kappaB ligand (RANKL) activation of NF-kappaB signaling and inhibit osteoclastogenesis in bone-derived cells. J Biol Chem. 2011;286:11492–11505.
  • Toussirot E, Abbas W, Khan KA, et al. Imbalance between HAT and HDAC activities in the PBMCs of patients with ankylosing spondylitis or rheumatoid arthritis and influence of HDAC inhibitors on TNF alpha production. PLoS ONE. 2013;8:e70939.
  • Yang S-R, Wright J, Bauter M, et al. Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. Am J Physiol Lung Cell Mol Physiol. 2007;292:L567–576.
  • Yang H, Zhang W, Pan H, et al. SIRT1 activators suppress inflammatory responses through promotion of p65 deacetylation and inhibition of NF-κB activity. PLoS ONE. 2012;7:e46364.
  • Knobloch J, Wahl C, Feldmann M, et al. Resveratrol attenuates the release of inflammatory cytokines from human bronchial smooth muscle cells exposed to lipoteichoic acid in chronic obstructive pulmonary disease. Basic Clin Pharmacol Toxicol. 2014;114:202–209.
  • Rajendrasozhan S, Yang S-R, Kinnula VL, et al. SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177:861–870.
  • Kim HY, Park SY, Lee SW, et al. Inhibition of HMGB1-induced angiogenesis by cilostazol via SIRT1 activation in synovial fibroblasts from rheumatoid arthritis. PLoS ONE. 2014;9:e104743.
  • Katto J, Engel N, Abbas W, et al. Transcription factor NFκB regulates the expression of the histone deacetylase SIRT1. Clin Epigenetics. 2013;5:11.
  • Dvir-Ginzberg M, Gagarina V, Lee EJ, et al. Tumor necrosis factor α-mediated cleavage and inactivation of SirT1 in human osteoarthritic chondrocytes. Arthritis Rheum. 2011;63:2363–2373.
  • Fernandes CA, Fievez L, Neyrinck AM, et al. Sirtuin inhibition attenuates the production of inflammatory cytokines in lipopolysaccharide-stimulated macrophages. Biochem Biophys Res Commun. 2012;420:857–861.
  • Zhang T, Kraus WL. SIRT1-dependent regulation of chromatin and transcription: linking NAD(+) metabolism and signaling to the control of cellular functions. Biochim Biophys Acta. 2010;1804:1666–1675.
  • Chen J, Xavier S, Moskowitz-Kassai E, et al. Cathepsin cleavage of sirtuin 1 in endothelial progenitor cells mediates stress-induced premature senescence. Am J Pathol. 2012;180:973–983.
  • Fusco S, Maulucci G, Pani G. Sirt1: def-eating senescence? Cell Cycle. 2012;11:4135–4146.
  • Wendling D, Vidon C, Abbas W, et al. Sirt1 activity in peripheral blood mononuclear cells from patients with rheumatoid arthritis. Joint Bone Spine. 2014;81:462–463.
  • Wendling D, Abbas W, Godfrin-Valnet M, et al. Dysregulated serum IL-23 and SIRT1 activity in peripheral blood mononuclear cells of patients with rheumatoid arthritis. PLoS ONE. 2015;10:e0119981.
  • Burmester GR, Feist E, Dörner T. Emerging cell and cytokine targets in rheumatoid arthritis. Nat Rev Rheumatol. 2014;10:77–88.
  • Listing J, Kekow J, Manger B, et al. Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab. Ann Rheum Dis. 2015;74:415–421.
  • Verhoeven F, Prati C, Maguin-Gaté K, et al. Glucocorticoids and endothelial function in inflammatory diseases: focus on rheumatoid arthritis. Arthritis Res Ther. 2016;18:258.
  • Verhoeven F, Totoson P, Maguin-Gaté K, et al. Glucocorticoids improve endothelial function in rheumatoid arthritis: a study in rats with adjuvant-induced arthritis. Clin Exp Immunol. 2017;188:208–218.
  • Sakaguchi N, Takahashi T, Hata H, et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature. 2003;426:454–460.
  • Abdin AA, Abd El-Halim MS, Hedeya SE, et al. Effect of atorvastatin with or without prednisolone on Freund’s adjuvant induced-arthritis in rats. Eur J Pharmacol. 2012;676:34–40.
  • Engler A, Tange C, Frank-Bertoncelj M, et al. Regulation and function of SIRT1 in rheumatoid arthritis synovial fibroblasts. J Mol Med. 2016;94:173–182.
  • Paolino S, Cutolo M, Pizzorni C. Glucocorticoid management in rheumatoid arthritis: morning or night low dose? Reumatologia. 2017;55:189–197.
  • Cutolo M. Glucocorticoids and chronotherapy in rheumatoid arthritis. RMD Open. 2016;2. DOI:10.1136/rmdopen-2015-000203
  • Poulsen RC, Watts AC, Murphy RJ, et al. Glucocorticoids induce senescence in primary human tenocytes by inhibition of sirtuin 1 and activation of the p53/p21 pathway: in vivo and in vitro evidence. Ann Rheum Dis. 2014;73:1405–1413.
  • Suzuki S, Iben JR, Coon SL, et al. SIRT1 is a transcriptional enhancer of the glucocorticoid receptor acting independently to its deacetylase activity. Mol Cell Endocrinol. 2018;461:178–187.
  • Moon M-H, Jeong J-K, Lee Y-J, et al. SIRT1, a class III histone deacetylase, regulates TNF-α-induced inflammation in human chondrocytes. Osteoarthr Cartil. 2013;21:470–480.
  • Liu TF, McCall CE. Deacetylation by SIRT1 reprograms inflammation and cancer. Genes Cancer. 2013;4:135–147.
  • Park SY, Lee SW, Lee SY, et al. SIRT1/adenosine monophosphate-activated protein kinase α signaling enhances macrophage polarization to an anti-inflammatory phenotype in rheumatoid arthritis. Front Immunol. 2017;8:1135.
  • Liu T, Zhang L, Joo D, et al. NF-κB signaling in inflammation. Signal Transduct Target Ther. 2017;2. DOI:10.1038/sigtrans.2017.23
  • Volonte D, Zou H, Bartholomew JN, et al. Oxidative stress-induced inhibition of Sirt1 by Caveolin-1 promotes p53-dependent premature senescence and stimulates the secretion of interleukin 6 (IL-6). J Biol Chem. 2015;290:4202–4214.
  • Hah Y-S, Cheon Y-H, Lim HS, et al. Myeloid deletion of SIRT1 aggravates serum transfer arthritis in mice via nuclear factor-κB activation. Plos One. 2014;9:e87733.
  • Zhu X, Liu Q, Wang M, et al. Activation of Sirt1 by resveratrol inhibits TNF-α induced inflammation in fibroblasts. PLoS ONE. 2011;6:e27081.
  • Liao J, Keiser JA, Scales WE, et al. Role of epinephrine in TNF and IL-6 production from isolated perfused rat liver. Am J Physiol. 1995;268:R896–901.
  • Villalba JM, Alcaín FJ. Sirtuin activators and inhibitors. Biofactors. 2012;38:349–359.
  • Leoni F, Zaliani A, Bertolini G, et al. The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines. Proc Natl Acad Sci USA. 2002;99:2995–3000.
  • Choo QY, Ho PC, Lin HS. Histone deacetylase inhibitors: new hope for rheumatoid arthritis? Curr Pharm Des. 2008;14:803–820.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.